Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue. - Wikidata - awgldk - TriplyDB

Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue.

Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue.

http://www.wikidata.org/entity/Q35083825

about

Paradoxical antiproliferative effect by a murine mammary tumor-derived epithelial cell line Quantification of mineralized bone response to prostate cancer by noninvasive in vivo microCT and non-destructive ex vivo microCT and DXA in a mouse model.Study of matrix metalloproteinases and their inhibitors in prostate cancer.New clinically relevant, orthotopic mouse models of human chondrosarcoma with spontaneous metastasis Tumor-stromal interactions in bone metastasis.The miR-124-prolyl hydroxylase P4HA1-MMP1 axis plays a critical role in prostate cancer progression.Bone-induced c-kit expression in prostate cancer: a driver of intraosseous tumor growth.Tumor microenvironment regulates metastasis and metastasis genes of mouse MMTV-PymT mammary cancer cells in vivo.Homing of cancer cells to the bone Fibronectin-alpha4beta1 integrin interactions regulate metalloproteinase-9 expression in steatotic liver ischemia and reperfusion injury.Prostate cancer-associated membrane type 1-matrix metalloproteinase: a pivotal role in bone response and intraosseous tumor growth.Piwil2 modulates the invasion and metastasis of prostate cancer by regulating the expression of matrix metalloproteinase-9 and epithelial-mesenchymal transitions.Gene expression analysis of bone metastasis and circulating tumor cells from metastatic castrate-resistant prostate cancer patients.Potentiation of the antitumor activity of adriamycin against osteosarcoma by cannabinoid WIN-55,212-2 Suppressive effect of 19-nor-1α-25-dihydroxyvitamin D2 on gastric cancer cells and peritoneal metastasis model.Overexpression of FoxM1 is associated with tumor progression in patients with clear cell renal cell carcinoma.Piceatannol inhibits MMP-9-dependent invasion of tumor necrosis factor-α-stimulated DU145 cells by suppressing the Akt-mediated nuclear factor-κB pathway.Prostate cancer cell-derived urokinase-type plasminogen activator contributes to intraosseous tumor growth and bone turnover.Proteases as modulators of tumor-stromal interaction: primary tumors to bone metastases.The significance of TNFAIP8 in prostate cancer response to radiation and docetaxel and disease recurrence.S100A7 enhances invasion of human breast cancer MDA-MB-468 cells through activation of nuclear factor-κB signaling TW-37, a small-molecule inhibitor of Bcl-2, inhibits cell growth and invasion in pancreatic cancer.Bone marrow stromal cells enhance prostate cancer cell invasion through type I collagen in an MMP-12 dependent manner.miR-221 promotes growth and invasion of hepatocellular carcinoma cells by constitutive activation of NFκB.The osteoblastic and osteoclastic interactions in spinal metastases secondary to prostate cancer.Osteoclasts are important for bone angiogenesis.Diagnostic and prognostic role of matrix metalloproteases in cancer.CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.Possible role of matrix metalloproteinases (MMPs) in hyperostosis of intracranial meningiomas.Targeting CXCR4 with CTCE-9908 inhibits prostate tumor metastasis.ETV5 as a regulator of matrix metalloproteinase 2 in human chondrosarcoma.Obesity-related systemic factors promote an invasive phenotype in prostate cancer cells.Interactions between human osteoblasts and prostate cancer cells in a novel 3D in vitro model.Characterization of the expression of variant and standard CD44 in prostate cancer cells: identification of the possible molecular mechanism of CD44/MMP9 complex formation on the cell surface.CXCL12/CXCR4 transactivates HER2 in lipid rafts of prostate cancer cells and promotes growth of metastatic deposits in bone.Host matrix metalloproteinase-9 contributes to tumor vascularization without affecting tumor growth in a model of prostate cancer bone metastasis.Are matrix metalloproteinases relevant therapeutic targets for prostate cancer bone metastasis?Cancer interaction with the bone microenvironment: a workshop of the National Institutes of Health Tumor Microenvironment Study Section.Adenovirus-mediated expression of TIMP-1 and TIMP-2 in bone inhibits osteolytic degradation by human prostate cancer.Immunohistochemical analysis of the role and relationship between Notch-1 and Oct-4 expression in urinary bladder carcinoma.

P2860

Q33301048-42AC117C-68CD-46A9-970D-06AABD9C1410 Q33548724-6CE56904-E41F-4978-AB70-33BE742CC22A Q33708162-F4C54A10-A902-4BD9-B9FB-25975891C1EB Q33986627-0CFD76E5-1368-40F9-B4B0-1B15D571AC33 Q34022223-3B325C41-EA9B-46A8-9AFF-D8A9ED32B98B Q34334347-BC0EEECF-8E2E-4791-991A-210B2EA36191 Q34353130-BA16B1B0-9F5A-4A74-9E7C-EC3C89E07969 Q34921801-8E0807F0-43E2-468A-B525-98317E8EE0B5 Q35603135-954BAE5F-278E-4021-8D42-7BBF6119FF2D Q35750203-2FD01790-E88C-4911-8A5E-78117E1DA74F Q35855547-DEE3A206-3172-49FA-90E3-AEE01B710BBB Q35943167-705A5E3A-5E7D-41B4-8B29-8C92E89E9F4D Q35956586-0A88DC49-3747-4A87-A914-3E8EE4301F6D Q36085919-0B47C2F8-684F-4D8A-ABF9-E7B2D01D1A2B Q36195649-623FA255-B6A0-4B5B-BC98-90D38EFB62A6 Q36380333-480A66B7-9CA5-403A-BFD7-2D6E55ABE7EB Q36475828-0ADC4B94-E6F1-4991-892D-6F4D409F960E Q36640228-B227B3C7-8D3F-45B7-AC29-4F35E36AF8F3 Q36707418-C13FFC7B-9E0F-48AD-A8D3-766EC0E24920 Q36751712-32347F52-1E34-42DC-A21B-EFC5ADBB5408 Q36798341-266DCDD2-BA34-48E5-9E80-A3E090BC08D9 Q37154117-DECC7586-DAB3-409C-BB71-04829C9B0FFB Q37347935-64B432B7-4319-4CCF-84E7-E898A5BFF382 Q37448131-648A846D-8224-481B-8C04-2DFFAEEC0C64 Q37615017-9F45BEA9-AE26-4A6B-9C4A-40FACCDB3379 Q37706007-1145B09D-8410-4624-AB41-F6A1E60AE7A9 Q38089795-6C4EFBD5-4667-43E7-BFB0-B6C85A3381C6 Q38321879-1C0B5608-4B0C-4C2F-A374-BA7A04FE0943 Q38465447-9F57D97E-CEF0-40C0-91AB-4606EF4909A1 Q39029582-93D69585-F7B1-4D2F-86E3-9709E10824F4 Q39280850-1FA3F157-1B75-4C84-A4DE-840F759F9F04 Q39396694-F904B94D-49FC-4083-8F3E-F179A4F0B9F4 Q39613119-5327BF27-B45F-4FAA-8F3C-00C4E93FC452 Q39828194-6689C4B2-C19A-4765-B925-39644255E06B Q40003028-0A263ECB-41E9-4636-9321-F65D6D28C00A Q40202584-486D52DB-DB4D-44A1-9840-05168D66AEBE Q41814257-4BC260C8-7E59-41B5-BD34-D1847DB8C963 Q43018265-499B2917-F8E1-44B0-801C-277CA34EDDB9 Q45870930-1A970660-29C1-45EB-8E44-83B3FFB2BD8B Q46619102-B7065117-EA51-4B30-AEC3-2BDA7F956E3D

P2860

Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue.

http://www.wikidata.org/entity/Q35083825

description

2005 nî lūn-bûn

@nan

2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Matrix metalloproteinase activ ...... cancer bone metastasis tissue.

@ast

Matrix metalloproteinase activ ...... cancer bone metastasis tissue.

@en

type

label

Matrix metalloproteinase activ ...... cancer bone metastasis tissue.

@ast

Matrix metalloproteinase activ ...... cancer bone metastasis tissue.

@en

prefLabel

Matrix metalloproteinase activ ...... cancer bone metastasis tissue.

@ast

Matrix metalloproteinase activ ...... cancer bone metastasis tissue.

@en

P1433

Q35083825-4BDAFC6C-8CBD-49CE-A191-2B6D891E4D11

P1476

Q35083825-80E31D67-3BCF-4EAB-8660-369A082F27A0

P2093

Q35083825-1600FC91-CB36-4FB1-BFAC-C2BE9C3B7CBD

Q35083825-1D2D14EC-5346-4818-A217-D59A39CCF8D3

Q35083825-3D55F3D6-A385-4903-8305-CB278BE94F29

Q35083825-5CB00962-46F6-41A2-BB7C-AD939F16F17D

Q35083825-6771641E-9DA1-474A-B47F-411E1EF40906

Q35083825-855D8D92-AC1F-499B-9266-696A29AB798F

Q35083825-91AD8D12-F082-4BF5-91B8-D9218373AE18

Q35083825-9E676357-7CA5-489D-B3E1-920024FB7733

Q35083825-A6C9E867-A2BA-4B34-8F33-BB3D50CAE62E

Q35083825-A9BFDC96-3077-49DA-9532-D8397522C6A9

P2860

Q35083825-165DF634-EFCD-421C-8E50-D729FA71C64B

Q35083825-1F5A271E-9AC6-4DBC-8AD6-E9778B844C36

Q35083825-2422BB43-4B8F-4E9A-ABA4-74EB9FFA3A0F

Q35083825-27D1CF73-A214-4FEC-86DD-4435521A0F78

Q35083825-297D1940-6A88-40C7-AA70-C5DD1AE6FFC5

Q35083825-2AFF8DCB-41A5-4CDB-B932-1833C53EBF5B

Q35083825-2CB62935-1859-49E2-A6B0-E3373372634E

Q35083825-35543C00-BA58-4868-81DA-2B7AAC90B2A9

Q35083825-3E255CC4-1F2D-4DE3-A777-AE29EE656F9D

Q35083825-447F385D-C995-49C0-A18B-D2EFEE41B68D

P304

Q35083825-BA01B0E2-C5DD-4C4F-904B-171F104C5C29

P31

Q35083825-BCBD36EA-A99F-45BB-BBE9-AC401D64914E

P356

Q35083825-8C892E9F-C32D-4448-A3D2-AFCC2F4F625C

P407

Q35083825-427208E7-3D24-469D-A4ED-7EA5D92E6AD0

P433

Q35083825-CB547F7A-664C-4DDE-8FC7-48D6EC224BEE

P478

Q35083825-D09480AC-1FBE-4BDC-BC4C-D4A776887A00

P577

Q35083825-2012A38A-9847-498E-9EDA-0ECCED04042A

P5875

Q35083825-4302FED2-C988-4D58-9449-D797CBB387BE

P698

Q35083825-D16B97C5-4261-4FFB-B1C4-505385FAFB70

P932

Q35083825-9B2F6846-4EA4-4437-AB0D-AE3DD9C9D944

P356

S0002-9440(10)62337-1

P1433

The American Journal of Pathology

P1476

Matrix metalloproteinase activ ...... cancer bone metastasis tissue.

@en

P2093

Bonnie F Sloane

http://www.w3.org/2001/XMLSchema#string

J Carlos Trindade Filho

http://www.w3.org/2001/XMLSchema#string

Margarida Bernardo

http://www.w3.org/2001/XMLSchema#string

Michael L Cher

http://www.w3.org/2001/XMLSchema#string

Mingxin Che

http://www.w3.org/2001/XMLSchema#string

R Daniel Bonfil

http://www.w3.org/2001/XMLSchema#string

Rafael Fridman

http://www.w3.org/2001/XMLSchema#string

Shijie Sheng

http://www.w3.org/2001/XMLSchema#string

Sreenivasa Chinni

http://www.w3.org/2001/XMLSchema#string

Ulka Vaishampayan

http://www.w3.org/2001/XMLSchema#string

P2860

Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis

MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes

Cathepsin D specifically cleaves the chemokines macrophage inflammatory protein-1 alpha, macrophage inflammatory protein-1 beta, and SLC that are expressed in human breast cancer

Activation of pro-gelatinase B by endometase/matrilysin-2 promotes invasion of human prostate cancer cells

Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2)

Activation of progelatinase B (proMMP-9) by active collagenase-3 (MMP-13)

Metastasis to bone: causes, consequences and therapeutic opportunities

A matrix metalloproteinase inhibitor, batimastat, retards the development of osteolytic bone metastases by MDA-MB-231 human breast cancer cells in Balb C nu/nu mice.

Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial.

Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients.

P304

1173-1186

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0002-9440(10)62337-1

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

166

http://www.w3.org/2001/XMLSchema#string

P577

2005-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7943199

http://www.w3.org/2001/XMLSchema#string

P698

15793297

http://www.w3.org/2001/XMLSchema#string

P932

1602391

http://www.w3.org/2001/XMLSchema#string